Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for DCTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 121.14M
March 31, 2026 112.71M
December 31, 2025 111.22M
September 30, 2025 114.85M
June 30, 2025 104.99M
March 31, 2025 80.23M
December 31, 2024 68.75M
September 30, 2024 8.571M
June 30, 2024 4.192M
March 31, 2024 14.62M
December 31, 2023 15.78M
September 30, 2023 24.72M
June 30, 2023 -0.242M
March 31, 2023 5.292M
December 31, 2022 -5.859M
September 30, 2022 -5.246M
June 30, 2022 -2.846M
March 31, 2022 5.225M
December 31, 2021 11.95M
September 30, 2021 11.73M
June 30, 2021 15.16M
March 31, 2021 20.01M
December 31, 2020 22.08M
September 30, 2020 3.276M
June 30, 2020 7.702M
Date Value
March 31, 2020 -8.005M
December 31, 2019 -6.357M
September 30, 2019 -18.82M
June 30, 2019 -29.73M
March 31, 2019 -23.78M
December 31, 2018 -14.94M
September 30, 2018 -4.865M
June 30, 2018 -13.09M
March 31, 2018 -6.202M
December 31, 2017 0.678M
September 30, 2017 -1.85M
June 30, 2017 0.867M
March 31, 2017 -0.586M
December 31, 2016 -1.49M
September 30, 2016 4.486M
June 30, 2016 5.43M
March 31, 2016 7.858M
December 31, 2015 8.601M
September 30, 2015 13.52M
June 30, 2015 13.11M
March 31, 2015 16.42M
December 31, 2014 18.14M
September 30, 2014 20.68M
June 30, 2014 25.18M
March 31, 2014 29.65M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M
AtriCure, Inc. 516.43M
Baxter International, Inc. 6.206B

Shareholders Equity (Quarterly) Related Metrics